Inventor
HAMM SHARON
US16 patents
⚠️ This page may combine multiple inventors who share the name “HAMM SHARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMNEAL PHARMACEUTICALS LLC
7 patentsUS11654124B2May 23, 2023
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
AMNEAL PHARMACEUTICALS LLC2 citations71
US11491125B1Nov 8, 2022
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
AMNEAL PHARMACEUTICALS LLC3 citations71
US12383522B2Aug 12, 2025
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
AMNEAL PHARMACEUTICALS LLC0 citations60
US12011502B2Jun 18, 2024
Compositions and methods of administering baclofen
AMNEAL PHARMACEUTICALS LLC0 citations60
US11931328B2Mar 19, 2024
Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
AMNEAL PHARMACEUTICALS LLC0 citations60
US11850225B2Dec 26, 2023
Baclofen formulations and methods of minimizing patient exposure to metabolite variations
AMNEAL PHARMACEUTICALS LLC0 citations60
US11523984B1Dec 13, 2022
Compositions and methods of administering baclofen
AMNEAL PHARMACEUTICALS LLC0 citations60
SAOL INT DEVELOPMENT LTD
3 patentsUS11083695B2Aug 10, 2021
Injectable phenol formulations and methods of manufacture
SAOL INT DEVELOPMENT LTD0 citations58
US11083694B2Aug 10, 2021
Injectable phenol formulations and methods of their use
SAOL INT DEVELOPMENT LTD0 citations58
US10959962B2Mar 30, 2021
Injectable phenol formulations and methods of their use
SAOL INT DEVELOPMENT LTD0 citations58
SAOL INTERNATIONAL LTD
2 patentsRECRO GAINESVILLE LLC
2 patentsUS10213389B2Feb 26, 2019
Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
RECRO GAINESVILLE LLC0 citations50
US9463166B2Oct 11, 2016
Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
RECRO GAINESVILLE LLC0 citations50